Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ratner

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Nature Biotechnology|March 11, 2016
Sanofi drops MannKind's inhaled insulinMark Ratner
Nature Biotechnology|February 9, 2006
A turbulent year at the agencyMark Ratner
Nature Biotechnology|September 12, 2012
Biotechs opt for alternative floatation strategyMark Ratner
Nature Biotechnology|February 7, 2015
Roche swallows Ariosa, grabs slice of prenatal test marketMark Ratner
Nature Biotechnology|August 9, 2011
FDA panel votes to pull Avastin in breast cancer, againMark Ratner
Nature Biotechnology|November 9, 2010
Novartis eyes oral MS drug as potential blockbusterMark Ratner
Nature Biotechnology|September 11, 2010
Cochrane meta-analysis on alpha-1 antitrypsin prompts furorMark Ratner
Nature Biotechnology|April 12, 2017
Trade groups laud Gottlieb FDA choice, silent on NIH cutbackMark Ratner
Nature Biotechnology|September 12, 2012
GSK buys partner Human Genome SciencesMark Ratner
Nature Reviews. Drug Discovery|May 21, 2005
FDA pharmacogenomics guidance sends clear message to industryMark Ratner
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Nature Biotechnology|March 11, 2016
Sanofi drops MannKind's inhaled insulinMark Ratner
Nature Biotechnology|February 9, 2006
A turbulent year at the agencyMark Ratner
Nature Biotechnology|September 12, 2012
Biotechs opt for alternative floatation strategyMark Ratner
Nature Biotechnology|February 7, 2015
Roche swallows Ariosa, grabs slice of prenatal test marketMark Ratner
Nature Biotechnology|August 9, 2011
FDA panel votes to pull Avastin in breast cancer, againMark Ratner
Nature Biotechnology|November 9, 2010
Novartis eyes oral MS drug as potential blockbusterMark Ratner
Nature Biotechnology|September 11, 2010
Cochrane meta-analysis on alpha-1 antitrypsin prompts furorMark Ratner
Nature Biotechnology|April 12, 2017
Trade groups laud Gottlieb FDA choice, silent on NIH cutbackMark Ratner
Nature Biotechnology|September 12, 2012
GSK buys partner Human Genome SciencesMark Ratner
Nature Reviews. Drug Discovery|May 21, 2005
FDA pharmacogenomics guidance sends clear message to industryMark Ratner
Pageof 11